Future US Coagulation Market: Growth Opportunities and Business Expansion Strategies
NEW YORK, Dec. 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Future US Coagulation Market: Growth Opportunities and Business Expansion Strategies
This report presents a comprehensive analysis of the US coagulation market, including:
- Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.
- Placement estimates for major automated and semiautomated systems.
- Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of coagulation technologies and their potential market applications.
- Major opportunities for coagulation instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 424 pages and 18 tables
Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
0 Structure and Composition
0 Classification
0 Origin of AIDS
0 Animal Lentivirus Systems
0 Virus Receptos
0 HIV Infections in Humans
- Pathogenesis & Pathology: Overview of
HIV Infection Course
0 CD4T Lymphocytes and Memory Cells
0 Monocytes and Macrophages
0 Lymphoid Organs
0 Neural Cells
0 Viral Coinfections
- Clinical Findings
0 Plasma Viral Load
0 Pediatric AIDS
- Neurologic Disease
- Opportunistic Infections
- Cancer
0 Immunity
- Virus Isolation
- Serology
- Detection of Viral Nucleic
Acid and Antigens
0 Infectivity
0 Epidemiology
- Worldwide Spread of AIDS
- United States
- Routes of Transmission
b. Diagnostic Tests
0 Laboratory Diagnosis
- Enzyme Immunoassay Interpretation
- Specific, Sensitivity, and Predictive
Value of Enzyme Immunoassays
0 Competition Assays
0 Western Blot Technique
0 Immuno-Fluorescence Assay (IFA)
0 Radioimmunoprecipitation
0 HIV-1/HIV-2 Combination Testing
0 Methods of HIV-Antigen Detection
0 Antigen Assays and Blood Screening
0 Urine Tests
0 Immunopathogenic Mechanism of HIV Infection
0 DNA Probes
- Overview
- Quantitative Polymerase Chain Reaction
- In Situ PCR
- Needed Improvements
0 Viral Load/Drug Resistance Testing
0 Genotype and Phenotype Testing
0 Blood Banking Consideration
c. Vaccines and Drugs
- Antiviral Drugs
- Vaccines Against HIV
0 Transmission of HIV in Blood Products
0 HIV Transmission in Transplant and
Artificial Insemination Recipients
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
0 Identification from Culture
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
0 Chlamydia Psittaci
0 Chlamydia Pneumoniae
0 Chlamydia Trachomatis
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
0 Pediatric Infections
0 Epidemiology
b. Diagnostic Tests
0 Counterimmunoelectrophoresis
0 Fluorescent-Antibody Assays
0 Poloymerase Chain Reactions
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
0 Herpangina
0 Hand-foot-and-mouth syndrome
0 Hepidemic Conjuctivitis
0 Pharingitis
0 Epidemic Pleurodynia
0 Myodarditis,Pericarditis
0 Overwhelming Infection of the Newborn
0 Acute Aseptic Meningitis
0 Undifferentiated Febrile Illness
0 Fever with upper respiratory infection
0 Encephalitis
0 Asymptomatic Infection
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob's Disease
a. Background
0 Blood Transmission
b. Diagnostic Tests
0 Major Commercial and Academic Players
- Bayer
- Disease Sciences/Bio Tec Global
- Imperial College of Medicine
- Ortho-Clinical Diagnostics
- Pall
- ProMetic Life Sciences
- Proteome Sciences/Idexx
- Q-One Biotech
- Serono
- U.S. Agricultural Research Service
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
0 Histologic
0 Laboratory Parasitology
0 Serodiagnosis
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
0 Asymptomatic Infection
0 Diarrhea in Immunocompetent Persons
0 Diarrhea in Immunocompromisedersons
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
0 Chorioretinitis
0 Gastrointestinal
0 Central Nervous System Disease
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
0 Epidemiology
0 Hemorrhagic Fever
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
0 Role of Escherichia Coli in
Causing Diarrhea
0 EPEC
0 ETEC
0 EIEC
0 EHEC
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
0 Acute Aseptic Miningitisis
0 Encephalitis
0 Exanthems
0 Respiratory Disease
0 Myope;ricarditis
0 Neonatal Infections
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
0 Viral Isolation and Identification
0 Antibody Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
0 Life Cycle and Morphology
0 Morphology of Trophozoites
0 Clinical Disease
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
0 Identification of the Agent
0 Transmission
0 Other Rodent Hantaviruses
0 Distribution
0 Hantavirus Diseases
0 Epidemiology
0 Addendum in Proof-Northeastern Connection
0 Previously Unknown Pathogens
0 Cases Nationwide
b. Diagnostic Tests
0 An Immunohistochemistry Approach
0 Hantavirus Rapid Diagnostic Test
0 ELISA Diagnosis of Hantavirus Pulmonary
Syndrome
0 IgG ELISA
0 IgM Capture ELISA
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
0 Pathogenesis
0 Role in Peptic Ulcer Disease
0 Role in Gastric Cancer
0 Nonulcer Dyspepsia
b. Diagnostic Tests
c. Vaccines and Drugs
0 Specific Therapeutic Regimens
0 Who Should Be Treated?
0 Participants in Controlled Clinical Trials
0 Patients with Refractory Peptic Ulcer
0 Patients with Refractory NUD
0 Patients in High-Risk Groups for Gastric
Cancer
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
0 Classification
0 Transmission of Infection
0 Occupational Hazards
0 Acute Hepatitis
0 Diagnosis of Acute Infection
0 Chronic Hepatitis
0 HCV and Other Chronic Liver Diseases
0 Alcoholic Liver Disease
0 Hepatitis B Coinfection
0 Cirrhosis and Hepatocellular Carcinoma
0 Diagnostic Tests
0 Possible Indications for HCV RNA Testing
0 Conclusions and Future Direction
e. Hepatitis D
0 Historical Perspective
0 Epidemiology
0 HBV-HDV "Coinfection" vs. "Superinfection"
0 Methods of Detecting HDV
0 Prevention
f. Hepatitis E
0 Background
0 Prevalence of the Disease
0 Diagnostic Tests
0 Epidemiologic Serosurveys
0 Serologic Cross-Reactivity
g. Hepatitis G
0 Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
0 HIV-6 Infections
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
0 Clinical Description
0 Clinical Case Definition
0 Laboratory Criteria for Diagnosis
0 Case Classification
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
0 Potential Diagnositic Problems with Positive
Patients from Non-endemic Areas
- Patient
- Laboratory
- Physician
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
0 Development of Polysaccharide Vaccines
0 Quadrivalent Vaccine Development
0 Meningococcal A.C.Y. & W-135 Vaccines
0 Efficacy of Group C Vaccine
0 Efficacy of Group A Vaccine
0 Combinations of Group A and C Vaccines
0 Group B Efficacy Trials
0 Future Direction
43. Microsporidium
a. Background
0 Prevalence and Geographic Distribution
0 Sources of Human Infection and Transmission
b. Diagnostic Tests
0 Light Microscopic Examination of Stool
Specimens By Chromotrope Staining
0 Stool Concentration Methods
0 Chemofluorescent Agents
0 Giemsa Staining of Stool Specimens
0 Cytologic Diagnosis
0 Histologic Examination
0 Electron Microscopy
0 Examination of Bodily Fluids
0 Examination of Tissue Sections
0 Immunofluorescence Detection Procedures
0 Serology
0 Cell Culture
0 Approach to Diagnosis
0 Evaluation of Patients with Presumptive
Intestinal Microsporidiosis
0 Evaluation of Patients with Presumptive
Ocular Microsporidiosis
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
0 Efficacy of Vaccination
0 Future Issues
46. Mycoplasma
a. Background
0 Ureaplasma Urealyticum & Mycoplasma Hominis
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
0 HPV in Cancer
0 Cervical Neoplasm
b. Diagnostic Tests
c. Vaccines and Drugs
0 Prevention
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
0 Virulence Factors
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
0 Developing Countries
0 Elimination and Eradication of Measles
0 New Developments
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
0 The Genus Taphylococcus
b. Diagnostic Tests
c. Vaccines and Drugs
0 Prevention
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
0 Group A Streptococci
0 Group B Streptococci
62. Syphilis
a. Background
b. Diagnostic Tests
0 Biopsy
0 Rabbit Infectivity Testing
0 Other Diagnostic Modalities
c. Vaccines and Drugs
0 Syphilis and HIV Infection
0 Syphilis As a Cofactor for HIV Transmission
0 Basic Science Issues
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
0 Microscopic Characteristics
0 Cultural Characteristics
0 Detection of Antibodies
0 Skin Tests
0 MDRTB
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
- Clinical Syndromes
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
0 Abbott AxSYM
0 Abbott IMx/IMx Select
0 Anagen AN2000/AuraFlex
0 Siemens Immuno 1
0 Beckman Coulter Access
0 BioChem Pharma/SR1
0 BioMerieux/Vitek Vidas
0 Biotrol System 7000
0 Chiron ACS: Centaur
0 Chiron ACS: 180
0 Siemens ELISA Processor II/III
0 Siemens/Opus/Plus/Magnum
0 Siemens Stratus
0 J&J Diagnostics Vitros ECi
0 J&J Diagnostics/Amersham Amerlite
0 Olympus PK310
0 Roche Elecsys 1010/2010
0 Roche Cobas Core
0 Roche ES 300/300AL
0 Roche ES 22
0 Roche ES 33
0 Tosoh AIA-1200/1200DX/NexIA/600
0 Wallac/Pharmacia Delfia
C. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
0 Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture
Immunoassays
0 Enzyme Amplification
c. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
Appendix: Assumed Currency Exchange Rates
List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories
Performing Infectious Disease Tests by
Country
Worldwide All Market Segments Total Infectious
Disease Test Volume Forecast by Country
Worldwide All Market Segments Total Infectious
Disease Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market
Potential For Personal Testing
France Summary Table
All Infectious Diseases
Test Volume and Diagnostics Sales Forecast by Market Segment
France
Laboratories Performing Infectious Disease Tests by Market
Segment
France
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
France
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
France
All Market Segments Infectious Disease Test Volume Forecast
France
Hospital Laboratories Infectious Disease Test Volume Forecast
France
Blood Banks Infectious Disease Test Volume Forecast
France
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
France
All Market Segments Infectious Disease Diagnostics
Market Forecast
France
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
France
Blood Banks Infectious Disease Diagnostics Market Forecast
France
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
France
HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast
Forecast by Market Segment
France
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
HIV Ag Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
France
Adenovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Aeromonads Test Volume and Diagnostics Sales Forecast by
Market Segment
France
BEA Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Blastocystis Hominis Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Campylobacter Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Candida Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Chancroid Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Clostridium Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Cryptosporidium Test Volume and Diagnostics Sales Forecast
by Market Segment
France
CMV Test Volume and Diagnostics Sales Forecast by Market
Segment
France
E. Coli Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Echovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Enterovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
France
EBV Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Giardia Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Gonorrhea Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Hantavirus Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
France
HBsAg Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Hepatitis C Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Anti-HBc Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Anti-HBs Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Anti-HAV Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Hepatitis Delta Test Volume and Diagnostics Sales Forecast
by Market Segment
France
HBcAg Test Volume and Diagnostics Sales Forecast
by Market Segment
France
HBeAg Test Volume and Diagnostics Sales Forecast
by Market Segment
France
ALT/SGPT Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Legionella Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Lymphogranuloma Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Malaria Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Measles Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Meningitis Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Microsporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Mononucleosis Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Mumps Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Papilloma Virus Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Parvovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Pneumonia Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Polioma Viruses Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Pseudomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Rabies Test Volume and Diagnostics Sales Forecast by Market
Segment
France
RSV Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Rheumatoid Arthritis Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Rhinovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Rotavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Rubella Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Salmonella Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Scleroderma Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Septicemia Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Shigella Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Staphylococci Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Streptococci Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Syphilis Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Trichomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Tuberculosis Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Vibrio Test Volume and Diagnostics Sales Forecast by Market
Segment
France
Yersinia Test Volume and Diagnostics Sales Forecast by Market
Segment
France
AIDS Testing Market Diagnostics Sales by Major
Supplier
France
Adenovirus Testing Market Diagnostics Sales by
Major Supplier
France
Campylobacter Testing Market Diagnostics Sales by
Major Supplier
France
Candida Testing Market Diagnostics Sales by Major
Supplier
France
Chlamydia Testing Market Diagnostics Sales by Major
Supplier
France
CMV Testing Market Diagnostics Sales by Major
Supplier
France
Gonorrhea Testing Market Diagnostics Sales by Major
Supplier
France
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
France
Hepatitis C Testing Market Diagnostics Sales by
Major Supplier
France
Herpes Testing Market Diagnostics Sales by Major
Supplier
France
Lyme Disease Testing Market Diagnostics Sales by
Major Supplier
France
Meningitis Testing Market Diagnostics Sales by
Major Supplier
France
Mononucleosis Testing Market Diagnostics Sales by
Major Supplier
France
Mumps Testing Market Diagnostics Sales by Major
Supplier
France
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
France
RSV Testing Market Diagnostics Sales by Major Supplier
France
Rheumatoid Arthritis Testing Market Diagnostics
Sales by Major Supplier
France
Rotavirus Testing Market Diagnostics Sales by Major
Supplier
France
Rubella Testing Market Diagnostics Sales by Major
Supplier
France
Septicemia Testing Market Diagnostics Sales by Major
Supplier
France
Shigella Testing Market Diagnostics Sales by Major
Supplier
France
Streptococci Testing Market Diagnostics Sales by
Major Supplier
France
Syphilis Testing Market Diagnostics Sales by Major
Supplier
France
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
France
Trichomonas Testing Market Diagnostics Sales by
Major Supplier
France
Tuberculosis Testing Market Diagnostics Sales by
Major Supplier
France
Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base
To order this report:
In Vitro Diagnostic Industry: Future US Coagulation Market: Growth Opportunities and Business Expansion Strategies
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article